Biotest AG
OTC:BIESF
Biotest AG
OTC:BIESF
Price:
32
USD
Market Closed
Market Cap:
$1.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Biotest AG
OTC:BIESF
|
DE |
|
O
|
Olin Corp
F:OLN
|
US |
|
G
|
Genfit SA
XBER:XUP
|
FR |
|
C
|
Centrica PLC
OTC:CPYYY
|
UK |
|
Atos SE
F:AXI0
|
FR |
|
Gaya Abadi Sempurna Tbk PT
IDX:SLIS
|
ID |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
KR |
|
H
|
Hyungji Innovation and Creative Co Ltd
KOSDAQ:011080
|
KR |
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...
Wall St Price Targets
BIESF Price Targets Summary
Biotest AG
Biotest AG
There are no price targets for BIESF.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIESF's stock price target?
Not Available
BIESF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Biotest AG?
Projected CAGR
-1%
-1%
Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.
What is the Operating Income forecast for Biotest AG?
Projected CAGR
25%
25%
Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.
What is the Net Income forecast for Biotest AG?
Projected CAGR
14%
14%
The compound annual growth rate for Net Income over the next 1 year is 14%.
